Garry Arthur Neil - Dec 9, 2022 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
CEO and Chairman of the Board, Director
Signature
/s/ Christopher Sullivan, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Dec 9, 2022
Transactions value $
$9,207
Form type
4
Date filed
12/12/2022, 03:22 PM
Previous filing
Oct 7, 2022
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $9.21K +2.08K +29.19% $4.42* 9.22K Dec 9, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.